January 9, 2026
Ryoncil® Sales Increase 60% in December Quarter to US$35.1M
Strong Balance Sheet Reflects Revenue Growth and New $125M Five-Year FacilityNEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited…
Pharmaceuticals, Biotechnology and Life Sciences
Strong Balance Sheet Reflects Revenue Growth and New $125M Five-Year FacilityNEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited…
Trial to resolve all claims in the Anaptys and Tesaro/GSK dispute is scheduled for July 14-17, 2026 SAN DIEGO, Jan.…
Wondering what the Safe creatines for women in 2026 are? In this guide, a high-performance athlete and nutritionist helps you…
BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights…
NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology…
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a…
WALTHAM, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology…
International Medical Cannabis Revenue Increases 36%; Canadian Adult-Use Cannabis Revenue Grows 6% Tilray Pharma Achieves Record Quarterly Revenue U.S. Federal…
Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting advancement into Phase…
PORTLAND, Maine, Jan. 08, 2026 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company…